Development and validation of a risk prediction model for gestational diabetes mellitus in women of advanced maternal age during the first trimester

IF 4.4 2区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY The FASEB Journal Pub Date : 2025-01-18 DOI:10.1096/fj.202402129R
Yao Tang, Zhenzhen Liu, Li Li, Haiyan Liu, Xiaotian Li, Weirong Gu
{"title":"Development and validation of a risk prediction model for gestational diabetes mellitus in women of advanced maternal age during the first trimester","authors":"Yao Tang,&nbsp;Zhenzhen Liu,&nbsp;Li Li,&nbsp;Haiyan Liu,&nbsp;Xiaotian Li,&nbsp;Weirong Gu","doi":"10.1096/fj.202402129R","DOIUrl":null,"url":null,"abstract":"<p>With the global rise in advanced maternal age (AMA) pregnancies, the risk of gestational diabetes mellitus (GDM) increases. However, few GDM prediction models are tailored for AMA women. This study aims to develop a practical risk prediction model for GDM in AMA women. Data were obtained from a prospective observational cohort of AMA pregnant women from the Obstetrics and Gynecology Hospital in Shanghai, China. Singleton pregnancies with complete OGTT results at 24–28 weeks were selected and divided into training (70%) and validation (30%) sets. First-trimester predictors, including demographic, metabolic parameters, and clinical history, were evaluated for statistical significance. A multivariate logistic regression model was developed, with performance evaluated using receiver operating characteristic (ROC) curves and calibration plots. Predictors were primarily incorporated as categorical variables in a nomogram to enhance model convenience. A model using continuous predictors was also tested for comparison. A total of 1904 AMA women were included, with GDM incidence rates of 18.3% (243/1333) in the training set and 19.3% (110/571) in the validation set. Significant predictors for GDM diagnosis at 24–28 weeks included maternal age, GDM history, first-trimester fasting plasma glucose, mean arterial pressure, and triglyceride levels. The categorical model achieved an area under the ROC curve of 0.717 (95% CI: 0.682–0.753) in the training set and 0.702 (95% CI: 0.645–0.758) in the validation set. The Hosmer-Lemeshow test indicated good calibration (<i>p</i> = .97 in the training set; <i>p</i> = .66 in the validation set). The model with category and continuous predictors exhibited similar performance. This study developed and validated a practical early risk prediction nomogram for GDM in AMA women, using commonly available clinical data. The model shows good predictive performance and is resource-efficient, making it suitable for real-world clinical implementation.</p>","PeriodicalId":50455,"journal":{"name":"The FASEB Journal","volume":"39 2","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The FASEB Journal","FirstCategoryId":"99","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1096/fj.202402129R","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

With the global rise in advanced maternal age (AMA) pregnancies, the risk of gestational diabetes mellitus (GDM) increases. However, few GDM prediction models are tailored for AMA women. This study aims to develop a practical risk prediction model for GDM in AMA women. Data were obtained from a prospective observational cohort of AMA pregnant women from the Obstetrics and Gynecology Hospital in Shanghai, China. Singleton pregnancies with complete OGTT results at 24–28 weeks were selected and divided into training (70%) and validation (30%) sets. First-trimester predictors, including demographic, metabolic parameters, and clinical history, were evaluated for statistical significance. A multivariate logistic regression model was developed, with performance evaluated using receiver operating characteristic (ROC) curves and calibration plots. Predictors were primarily incorporated as categorical variables in a nomogram to enhance model convenience. A model using continuous predictors was also tested for comparison. A total of 1904 AMA women were included, with GDM incidence rates of 18.3% (243/1333) in the training set and 19.3% (110/571) in the validation set. Significant predictors for GDM diagnosis at 24–28 weeks included maternal age, GDM history, first-trimester fasting plasma glucose, mean arterial pressure, and triglyceride levels. The categorical model achieved an area under the ROC curve of 0.717 (95% CI: 0.682–0.753) in the training set and 0.702 (95% CI: 0.645–0.758) in the validation set. The Hosmer-Lemeshow test indicated good calibration (p = .97 in the training set; p = .66 in the validation set). The model with category and continuous predictors exhibited similar performance. This study developed and validated a practical early risk prediction nomogram for GDM in AMA women, using commonly available clinical data. The model shows good predictive performance and is resource-efficient, making it suitable for real-world clinical implementation.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
孕早期高龄产妇妊娠期糖尿病风险预测模型的建立与验证
随着全球高龄产妇(AMA)妊娠的增加,妊娠期糖尿病(GDM)的风险增加。然而,很少有GDM预测模型是为AMA女性量身定制的。本研究旨在建立一种实用的AMA女性GDM风险预测模型。数据来自中国上海妇产科医院AMA孕妇的前瞻性观察队列。选择24-28周OGTT结果完整的单胎妊娠,分为训练组(70%)和验证组(30%)。对包括人口统计学、代谢参数和临床病史在内的早期妊娠预测指标进行统计学意义评估。建立了多变量logistic回归模型,使用受试者工作特征(ROC)曲线和校准图对性能进行评估。预测因子主要作为分类变量纳入nomogram,以提高模型的方便性。还测试了使用连续预测因子的模型进行比较。共纳入1904名AMA女性,训练组GDM发病率为18.3%(243/1333),验证组为19.3%(110/571)。24-28周诊断GDM的重要预测因素包括产妇年龄、GDM病史、妊娠早期空腹血糖、平均动脉压和甘油三酯水平。分类模型在训练集中的ROC曲线下面积为0.717 (95% CI: 0.682-0.753),在验证集中的ROC曲线下面积为0.702 (95% CI: 0.645-0.758)。Hosmer-Lemeshow检验显示校准良好(p =。训练集为97;p =。(在验证集中为66)。具有类别和连续预测因子的模型表现出相似的性能。本研究利用常见的临床数据,开发并验证了一种实用的AMA女性GDM早期风险预测图。该模型具有良好的预测性能和资源效率,适用于实际临床应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
The FASEB Journal
The FASEB Journal 生物-生化与分子生物学
CiteScore
9.20
自引率
2.10%
发文量
6243
审稿时长
3 months
期刊介绍: The FASEB Journal publishes international, transdisciplinary research covering all fields of biology at every level of organization: atomic, molecular, cell, tissue, organ, organismic and population. While the journal strives to include research that cuts across the biological sciences, it also considers submissions that lie within one field, but may have implications for other fields as well. The journal seeks to publish basic and translational research, but also welcomes reports of pre-clinical and early clinical research. In addition to research, review, and hypothesis submissions, The FASEB Journal also seeks perspectives, commentaries, book reviews, and similar content related to the life sciences in its Up Front section.
期刊最新文献
Whole-body vibration protects against chronic high-altitude hypoxic bone loss by regulating the nitric oxide/HIF-1α axis in osteoblasts Novel role of the SOX4/CSNK2A1 axis in regulating TOP2A phosphorylation in breast cancer progression Dysregulated fatty acid metabolism in pericardiac adipose tissue of pulmonary hypertension due to left heart disease mice Cover Image Profiles of gut microbiota and metabolites for high risk of transgenerational depression-like behavior by paternal methamphetamine exposure
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1